$DCH

American Axle & Manufacturing Q2 Earnings Call Highlights

American Axle & Manufacturing (DCH) reported Q2 adjusted EBITDA of $389.6M (13.2% of sales). It recorded $15M in quarterly synergy benefits and targets $100M+ by year-end. Cash from operations was $107.5M and adjusted free cash flow $148.4M. Full-year guidance raised: sales $10.6B-$10.8B and adjusted EBITDA $1.36B-$1.425B.

Original reporting
Published Aug 9, 2026, 9:15 AM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 9, 2026, 9:16 AM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
American Axle & Manufacturing Q2 Earnings Call Highlights — source image
Decision brief

The 30-second read

$DCHBullishMed
01

Why it matters

Key trading inputs are the raised FY ranges (sales, adjusted EBITDA, adjusted free cash flow), the quantified synergy run-rate trajectory, and the balance-sheet de-risking via voluntary redemption of 2028 notes. Offsetting factors include legacy-business headwinds (lower volume and mix, India divestiture impact, and UAW stoppage costs) and disclosed sequential production declines in North America and Europe in the second half.

02

Market read

Traders can update DCH’s FY valuation inputs using the raised sales, EBITDA, and free-cash-flow ranges, plus leverage reduction from 2028 note redemptions, while monitoring 2H production declines and the pace of synergy realization.

03

What to watch

Synergy capture is still ramping toward $100M+ by year-end and $300M by year three; any slippage in procurement and operational initiatives could pressure margins despite current progress.

Relevance 8/10Novelty 7/10Timing: post-Q2 earnings call, guidance update for FY and 2H production expectations

Background

The piece summarizes American Axle & Manufacturing’s Q2 earnings call, focusing on integration savings from the Dowlais combination, cash flow and debt actions, and updated full-year guidance.

Company-level read

Ticker impact

$DCHBullishMedium confidence
Context

American Axle raised full-year guidance, including sales $10.6B to $10.8B and adjusted EBITDA $1.36B to $1.425B, citing integration progress and execution.

Expected impact

Moderately positive bias for the next few sessions as traders reprice FY cash flow and leverage trajectory, offset by disclosed 2H production declines.

Evidence & confidence

The article provides multiple concrete, decision-relevant datapoints: raised sales/EBITDA/FCF ranges, higher adjusted free cash flow, voluntary 2028 note redemption, and quantified 2H production declines. These are direct inputs to valuation and risk for DCH.

Market effects

Signals improving driveline margin and integration savings in auto supplier space, potentially supporting sentiment for other component makers tied to ICE and hybrid programs.

North America and Europe production decline guidance (about 4% and 8% sequentially) highlights regional demand seasonality and could influence regional supplier peers’ near-term expectations.

Trade uncertainty monitoring (USMCA discussions) adds a risk factor for cross-border sourcing and local-build strategies across the auto supply chain.

Counterpoint

Raised guidance may already reflect integration benefits, but disclosed 2H production declines and UAW stoppage costs suggest earnings durability could be more fragile than the headline ranges imply.

Key entities

  • American Axle & Manufacturing

    Guidance raise, synergy run-rate progress, improved cash flow, and voluntary 2028 note redemption discussed on the Q2 earnings call.

  • Dowlais

    Contribution to metal-forming margin improvement and source of engineering and purchasing efficiencies via integration synergies.

  • GM

    Next-generation full-size pickup truck launch expected to begin in the second half, with temporary production effects starting in September.

  • UAW

    Work stoppage at the Three Rivers, Michigan facility contributed about $8 million of costs in the legacy business.

Related articles

$DCHMed

Dauch Corporation’s (DCH) Costly Path To A Bigger Payoff

Dauch Corporation (NYSE:DCH) reported Q2 sales of about $3B and adjusted EBITDA of $389.6M (13.2% of sales), citing integration progress after its Dowlais acquisition. It raised full-year guidance: sales $10.6B-$10.8B, adjusted EBITDA $1.36B-$1.425B, adjusted FCF $260M-$325M. Net interest expense rose to $82.6M and GAAP net income fell to $1M.

$DCHMedAI 8/10

Dauch (DCH) Q2 2026 Earnings Call Transcript

Dauch Corporation (DCH) held its Q2 2026 earnings call, reporting sales of $2.96B versus $1.54B prior year, boosted by $1.45B from the Dowlais acquisition. Adjusted EBITDA was $389.6M (13.2%) and adjusted free cash flow $148.4M. Full-year guidance: sales $10.6B-$10.8B and adjusted EBITDA $1.36B-$1.425B. Net leverage was 2.6x.

$DCHMed

Dauch Corp (DCH): Results of Operations and Financial Condition

Dauch Corp (DCH) filed an SEC Form 8-K — Results of Operations and Financial Condition. Dauch Reports Second Quarter 2026 Financial Results Delivers Strong Performance and Operating Cash Flow DETROIT, August 7, 2026 -- Dauch Corporation ("Dauch") (NYSE: DCH; LSE: DCH) today reported its financial results for the second quarter 2026. Second Quarter 2026 Results • Sal

$DCHMedAI 9/10

Dauch Corporation (DCH) Reports Q1 2026 Sales Growth Amid Net Loss

Dauch Corp. (NYSE:DCH) reported Q1 2026 sales of $2.38 billion, up from $1.41 billion a year earlier, mainly attributed to its Dowlais Group acquisition. The company posted a net loss of $100.3 million ($0.52/share) but said Adjusted EBITDA was $308.5 million (13% of sales). Adjusted EPS rose to $0.34. For 2026, it projects sales of $10.3–$10.8 billion and Adjusted EBITDA of $1.3–$1.425 billion, expecting synergy benefits to exceed a $100 million run rate by year one.

$SNPSMedAI 9/10

How to Play SNPS Stock as Layoffs Hit Synopsys

Synopsys (SNPS) reported Q3 FY2026 earnings with revenue of $2.48B, up 42.4% YoY, and EPS of $3.91, beating estimates. The company raised its full-year outlook. Analysts maintain 'Buy' ratings with price targets up to $633, citing long-term growth potential in semiconductor design.

$GCOMed

102-year-old mall retailer quietly closes 25 stores

Genesco (GCO) closed 25 stores, including 17 Journeys locations, in Q2 fiscal 2027, per its earnings release. Net sales fell 3% YoY to $530M, with comparable sales down 1%. The company is shifting away from malls and remodeling stores to boost sales, with 4.0 Journeys stores showing 25% higher sales.